Status:
COMPLETED
Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain
Lead Sponsor:
Azad University of Medical Sciences
Conditions:
Symptomatic Irreversible Pulpitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The aim of this study is to determine whether inferior alveolar nerve block of ketorolac and lidocaine would improve the success rate in teeth with symptomatic irreversible Pulpitis. Design: In this ...
Detailed Description
The aim of this study is to determine whether inferior alveolar nerve block of ketorolac and lidocaine would improve the success rate in teeth with symptomatic irreversible Pulpitis. Design: In this r...
Eligibility Criteria
Inclusion
- patients with age ranged 18-65
- without systemic diseases;
- without any medicine consumption;
- nonsmoking;
- nonpregnant;
- non-breastfeeding;
- with symptomatic irreversible pulpitis (Visual Analog Scale ≥ 54) in one mandibular
- the molar that needs root canal treatment
Exclusion
- patients under 18 or above 65 years old
- with systemic diseases;
- with any medicine consumption;
- smoking;
- pregnant;
- breastfeeding;
- without symptomatic irreversible pulpitis (Visual Analog Scale ≥ 54) in one mandibular
- the molar that needs root canal treatment
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03410212
Start Date
February 15 2018
End Date
November 15 2018
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dental Branch, AZad UMS
Tehran, Iran